EVOLV TECHNOLOGIES HOLDINGS (EVLV)

US30049H1023 - Common Stock

2.86  +0.1 (+3.62%)

After market: 2.86 0 (0%)

Fundamental Rating

3

Taking everything into account, EVLV scores 3 out of 10 in our fundamental rating. EVLV was compared to 128 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of EVLV is average, but there are quite some concerns on its profitability. EVLV is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year EVLV has reported negative net income.
EVLV had a negative operating cash flow in the past year.
In the past 5 years EVLV always reported negative net income.
EVLV had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

EVLV has a Return On Assets of -31.63%. This is amonst the worse of the industry: EVLV underperforms 80.16% of its industry peers.
EVLV's Return On Equity of -63.06% is on the low side compared to the rest of the industry. EVLV is outperformed by 80.16% of its industry peers.
Industry RankSector Rank
ROA -31.63%
ROE -63.06%
ROIC N/A
ROA(3y)-21.13%
ROA(5y)-54.56%
ROE(3y)-38.14%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of EVLV (48.90%) is better than 85.71% of its industry peers.
In the last couple of years the Gross Margin of EVLV has grown nicely.
The Profit Margin and Operating Margin are not available for EVLV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.03%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

EVLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
EVLV has more shares outstanding than it did 1 year ago.
EVLV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EVLV has an Altman-Z score of -0.17. This is a bad value and indicates that EVLV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.17, EVLV is doing worse than 80.16% of the companies in the same industry.
EVLV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.17
ROIC/WACCN/A
WACC9.32%

2.3 Liquidity

A Current Ratio of 1.77 indicates that EVLV should not have too much problems paying its short term obligations.
The Current ratio of EVLV (1.77) is worse than 69.05% of its industry peers.
A Quick Ratio of 1.64 indicates that EVLV should not have too much problems paying its short term obligations.
EVLV has a Quick ratio (1.64) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.64

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.65% over the past year.
Looking at the last year, EVLV shows a very strong growth in Revenue. The Revenue has grown by 28.34%.
Measured over the past years, EVLV shows a very strong growth in Revenue. The Revenue has been growing by 156.06% on average per year.
EPS 1Y (TTM)32.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)28.34%
Revenue growth 3Y156.06%
Revenue growth 5YN/A
Sales Q2Q%16.61%

3.2 Future

Based on estimates for the next years, EVLV will show a very strong growth in Earnings Per Share. The EPS will grow by 27.05% on average per year.
Based on estimates for the next years, EVLV will show a very strong growth in Revenue. The Revenue will grow by 36.67% on average per year.
EPS Next Y21.89%
EPS Next 2Y27.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.16%
Revenue Next 2Y31.6%
Revenue Next 3Y49.35%
Revenue Next 5Y36.67%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

EVLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EVLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EVLV's earnings are expected to grow with 27.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.05%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EVLV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EVOLV TECHNOLOGIES HOLDINGS

NASDAQ:EVLV (5/31/2024, 7:00:02 PM)

After market: 2.86 0 (0%)

2.86

+0.1 (+3.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap444.96M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.63%
ROE -63.06%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 48.9%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)32.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y21.89%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.34%
Revenue growth 3Y156.06%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y